Public Service Announcements

In August, with the start of the New England Patriots preseason games, we began airing public service announcements on 93.7 WEEI Sports Radio and on 98.5 The Sports Hub. The public service announcements feature our clinicians talking about a variety of cancer-related topics as well as the progress being made in cancer care and research, and will run for the duration of the 2017-2018 season.

Keep an ear out for our public service announcements as you listen to 93.7 and 98.5!

PSAs

January 2018

Jeremy Abramson, MD
Clinical Director, Center for Lymphoma
Dr. Abramson talks about the scientific progress in cancer immunotherapy and explains that the Mass General Cancer Center is one of the 16 hospitals in the nation approved to use the new cellular immunotherapy, called CAR T-cell therapy, for advanced lymphoma in adults.
Listen to Dr. Abramson's PSA

Jonathan Jackson, PhD
Principal Investigator, Lazarex-MGH Cancer Care Equity Program
Dr. Jonathan Jackson reminds us of the importance of ensuring that all people have equal access to quality care. Join Us this February for Black Health Month Events.
Listen to Dr. Jackson's PSA #1 | Listen to Dr. Jackson's PSA #2  |  Listen to Dr. Jackson's PSA #3

Andrea McClatchey, PhD
Principal Investigator, Mass General Cancer Center
Dr. McClatchey talks about the importance of basic science, emphasizing the teamwork that’s necessary to better understand cancer, apply learnings, and advance patient care.
Listen to Dr. McClatchey's PSA

David P. Ryan, MD
Chief, Hematology/Oncology
Clinical Director, Mass General Cancer Center
Dr. David Ryan reminds us that although cancer is complex, clinicians and researchers at the Mass General Cancer Center are committed to making advancements in treatment options like clinical trials, targeted therapies and immunotherapies to better care for patients.
Listen to Dr. Ryan's PSA

December 2017

Jeremy Abramson, MD
Clinical Director, Center for Lymphoma
Dr. Abramson talks about the scientific progress in cancer immunotherapy. He explains that the Mass General Cancer Center is one of the 16 hospitals in the nation approved to use the new cellular immunotherapy, called CAR T-cell therapy, for advanced lymphoma in adults. Dr. Abramson shares that everyone at the Cancer Center is continuously working to find new ways to help patients.
Listen to Dr. Abramson's PSA #1 | Listen to Dr. Abramson's PSA #2

November 2017

Lecia V. Sequist, MD
Thoracic Oncologist, Center for Thoracic Cancers
Dr. Lecia Sequist reminds us that lung cancer can happen to smokers, but also to people who have never smoked. She advocates for improving awareness of the disease, and believes that doing so will improve funding to advance research and the discovery of new therapies to help patients.
Listen to Dr. Sequist's PSA

Jo-Anne Shepard, MD
Director of Thoracic Imaging
Dr. Jo-Anne Shepard explains that at Mass General we have highly specialized chest radiologists and the most advanced technology with the potential to detect lung cancer at earlier stages, when it has the best chance of being cured.
Listen to Dr. Shepard's PSA

October 2017

Lawrence Blaszkowsky, MD
Medical Director, Vernon Cancer Center at Newton-Wellesley Hospital
Dr. Larry Blaszkowsky emphasizes how important a collaborative relationship between care teams at Newton-Wellesley, in Boston, and in the community is for a patient’s cancer care.
Listen to Dr. Blaszkowsky's PSA

Connie D. Lehman, MD, PhD
Director of Breast Imaging, Department of Radiology
Dr. Connie Lehman reminds us that early detection saves lives. She encourages women to talk with their doctor about their breast cancer risk and when to be screened.
Listen to Dr. Lehman's PSA

September 2017

Gary Proulx, MD
Radiation Oncologist, Mass General Cancer Center
Director, Radiation Oncology, Center for Cancer Care, Exeter Hospital
Dr. Proulx talks about the peace of mind patients have knowing their care is managed by Mass General Cancer Center clinicians.
Listen to Dr. Proulz's PSA

Lecia Sequist, MD, MPH
Thoracic Oncologist, Center for Thoracic Cancers
Dr. Sequist reminds us that the best outcomes are achieved when cancer is caught early, and that Mass General Cancer Center is committed to advancing cutting-edge technologies to aid in early cancer detection.
Listen to Dr. Sequist's PSA

August 2017

Edwin Choy, MD, PhD
Director of Sarcoma Research, Mass General Cancer Center
Dr. Choy explains his team utilizes advanced technologies to understand sarcomas and gain insights into novel therapies for patients.
Listen to Dr. Choy's PSA

Andrea McClatchey, PhD
Principal Investigator, Mass General Cancer Center
Dr. McClatchey talks about the importance of basic science, emphasizing the teamwork that’s necessary to better understand cancer, apply learnings, and advance patient care.
Listen to Dr. McClatchey's PSA

PSAs Library

Listen to our library of public service announcements, featuring experts from the Mass General Cancer Center.

Gayle Blouin, PharmD
Clinical Oncology Pharmacy Lead
Dr. Blouin highlights the importance of communicating with your care team regarding specific medications you may be taking. As new advances are being made in cancer treatment, Dr. Blouin recommends keeping an accurate log of all medications you currently take.
Listen to Dr. Blouin's PSA

Leif Ellisen, MD, PhD
Program Director, Breast Medical Oncology
Dr. Ellisen reminds us that although every case of breast cancer is unique, advances in risk assessment, early detection, and prevention can benefit patients across the board.
Listen to Dr. Ellisen's PSA

Justin Gainor, MD
Thoracic Oncologist, Center for Thoracic Cancers
Dr. Justin Gainor shares that the FDA recently approved the first immunotherapies for treatment of advanced non-small cell lung cancer.
Listen to Dr. Gainor's PSA

Ted Hong, MD
Director, Gastrointestinal Services
Associate Director, Mass General Dept of Radiation Oncology
Dr. Ted Hong stresses the importance of a patient having access to highly specialized radiation oncology team members and their deep understanding of the technology and the cancers they’re treating. He believes this is the difference between good care and great care.
Listen to Dr. Hong's PSA

Dror Michaelson, MD, PhD
Director, Center for Genitourinary Cancers
Dr. Michaelson talks about how the Cancer Center’s close affiliation with Harvard Medical School has contributed to excellence in medical education, and the future of cancer care.
Listen to Dr. Michaelson's PSA

Beverly Moy, MD
Clinical Director, Center for Breast Cancer
Dr. Bev Moy talks about the importance of routine screenings, advanced technologies, multidisciplinary teams of breast specialists, and clinical trials.
Listen to Dr. Moy's PSA

Jeffrey Peppercorn, MD, MPH
Medical Oncologist, Center for Breast Cancer
Dr. Jeffrey Peppercorn reminds women and their families that with regular screenings, appropriate diagnosis, and the proper treatment, breast cancer can be curable. Diagnosing breast cancer early is key, so performing monthly self-exams, having routine mammograms, talking with your doctor and seeking care if diagnosed are critical.
Listen to Dr. Peppercorn's PSA

Erika Rosato, RN, MHA, OCN, NE-BC
Nurse Director, Infusion Unit and Termeer Center for Targeted Therapies
Erika Rosato talks about the critical role that oncology nurses play in a patient’s cancer experience, and about the special relationships they form with each and every person.
Listen to Erika's PSA

Krista Rubin, NP
Nurse Practitioner, Center for Melanoma
Nurse Practitioner Krista Rubin shares information about melanoma, the most serious form of skin cancer. She talks about some of the common causes, and the people who have a higher risk for skin cancer while also reminding us that anyone can develop melanoma. She stresses the importance of early diagnosis and treatment, and talks about exciting targeted therapies and immunotherapies that are improving outcomes for melanoma patients.
Listen to Krista's PSA

Joel Schwartz, MD
Network Development Medical Director, Medical Oncology
Dr. Joel Schwartz informs listeners about the Cancer Center’s network of collaborations with community hospitals in New England and the Southeastern US. He talks about the benefits to these relationships, saying that we work with community providers to ensure that patients receive the right care at the right time, in the right place.
Listen to Dr. Schwartz's PSA

Kenneth Tanabe, MD
Center for Gastrointestinal Cancers
Dr. Kenneth Tanabe shares that there are treatment options that may successfully eradicate liver cancer and that many patients with cirrhosis should talk with their doctor about routine screenings.
Listen to Dr. Tanabe's PSA